Amprius Technologies Inc. (AMPX)

Amprius Technologies is trading in the middle of a long slide: the stock closed at $9.17 on November 10, 2026, down 3.68% on the session, but still 0.99% above its 50-day average of $9.08 and 5.22% above its 20-day EMA of $8.71. The bigger picture is weak. The price sits 31.16% below its 200-day average of $13.32 and 62.15% below its 52-week high of $24.23, and the stock is down 62.15% below six months. Revenue grew 125.90% year on year in the latest quarter, but the company is still loss-making and trades at a price-to-sales ratio of 12.39 against a sector median of 4.0. Every one of the 11 analysts covering the stock rates it Buy, which sits oddly beside its price action.

The stock's trend is mixed rather than clearly negative. It sits 0.99% above its 50-day average, which has begun to act as short-term support, yet it is 31.16% below the 200-day average and the 50-day average itself is 31.16% below the 200-day average. That gap means the longer-term trend is still weighed down by the sell-off over the past six months, when the stock fell 51.30%. The MACD line is negative, and the RSI of 53.4 sits in the neutral zone, so momentum is neither pushing the stock up nor forcing it down sharply.

Revenue grew 125.90% in the latest quarter compared with a year earlier, far faster than the sector median of 11.7%. Growth has not reached the bottom line. The net profit margin is -32.8%, the operating margin is -12.63%, and return on equity is -36.07%, below the sector median of 17.8%. Debt is light, with a debt-to-equity ratio of 0.05, so the losses are not being driven by borrowing. Investors are paying for growth that the company has not yet turned into profit, which is why its price-to-sales ratio of 12.39 is well above the sector median of 4.0.

Amprius has beaten EPS estimates in two of the last four reports, and only once did a beat coincide with a lower share price in the first session. The May 6, 2026 report was a clear miss, with EPS of -$0.04 against an estimate of -$0.01, and the stock fell 27.40% in the next session. The August 4, 2026 report was also a miss, but the shares rose 8.42% that day. The reaction to results has been large in both directions, consistent with a stock whose typical daily move is 5.70%.

Insiders sold $86.7M of stock over the last 18 months across 33 sales, and made no open-market purchases in that period. Such sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than purchases would be. Still, the absence of insider buying in a stock down this far is something a reader should weigh alongside the analysts' Buy ratings.

The base case is that the stock keeps trading between its short-term averages and the 52-week low while the company works through losses. For the trend to improve, the price would need to reclaim the 200-day average of $13.32, which would require a sustained move well above where it trades now. Analysts' targets run from $14.00 to $30.00, with a median of $22.00, which is 139.9% above the price; that gap reflects the analysts' view of future growth, not a near-term price path. Analysts expect revenue to rise 92.6% this fiscal year to $140.6M and forecast an EPS of -$0.07 for 2026, improving to $0.10 in 2027. The shares have a beta of 2.38 and a typical daily move of 5.70%, so the price can swing sharply on little news. The case would weaken if the next report misses estimates again, as the August 4, 2026 and May 6, 2026 reports both did, or if revenue growth slows well below the sector median of 11.7%. Over the coming months, the level of profitability reported with each quarter will matter as much as the top-line growth.

Support sits at the 50-day average of $9.08, the nearest level below the price, followed by the 20-day EMA at $8.71 and the 52-week low of $7.02. The 52-week low is the most significant floor: a move there would take the stock to its weakest level of the past year. Resistance begins at the 200-day average of $13.32, which is the nearest level above the price and the first one the stock would have to clear to show its trend had improved.